Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nicolaas P. Schaap"'
Autor:
Jolien M.R. Van der Meer, Paul K.J.D. de Jonge, Anniek B. van der Waart, Alexander C. Geerlings, Jurgen P. Moonen, Jolanda Brummelman, Janne de Klein, Malou C. Vermeulen, Ralph J.A. Maas, Nicolaas P.M. Schaap, Janneke S. Hoogstad-van Evert, Petronella B. Ottevanger, Joop H. Jansen, Willemijn Hobo, Harry Dolstra
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Combining natural killer (NK) cell adoptive transfer with tumor-sensitizing chemotherapy is an attractive approach against recurrent ovarian cancer (OC), as OC is sensitive to NK cell-mediated immunity. Previously, we showed that CD34+ hematopoietic
Externí odkaz:
https://doaj.org/article/619acac2e57b40f7a452e2426b67db92
Autor:
Ralph Ja Maas, Janneke S Hoogstad-van Evert, Jolien Mr Van der Meer, Vera Mekers, Somayeh Rezaeifard, Alan J Korman, Paul Kjd de Jonge, Jeannette Cany, Rob Woestenenk, Nicolaas Pm Schaap, Leon F Massuger, Joop H Jansen, Willemijn Hobo, Harry Dolstra
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Advanced ovarian cancer (OC) patients have a poor 5-year survival of only 28%, emphasizing the medical need for improved therapies. Adjuvant immunotherapy could be an attractive approach since OC is an immunogenic disease and the presence of tumor-in
Externí odkaz:
https://doaj.org/article/2eddf0d46af94ea7b8105cc99fe02594
Autor:
Burak Kalin, Mariëtte ter Borg, Rebecca Wijers, Judith A.E. Somers, Bronno van der Holt, Cornelis A.M. van Bergen, Eefke J. Petersen, Jurgen Kuball, Ellen Meijer, Nicolaas P.M. Schaap, Sacha S. Zeerleder, Annoek E. Broers, Eric Braakman, J.H. Frederik Falkenburg, Cor H.J. Lamers, Jan J. Cornelissen
Publikováno v:
HemaSphere, Vol 3, Iss 5 (2019)
Externí odkaz:
https://doaj.org/article/ad6bd82989bf4efba299003556fa59bf
Autor:
Yves Chalandon, Jakob R. Passweg, Cesare Guglielmi, Simona Iacobelli, Jane Apperley, Nicolaas P.M. Schaap, Jürgen Finke, Marie Robin, Roberta Fedele, Dominique Bron, Ibrahim Yakoub-Agha, Anja van Biezen, Theo de Witte, Nicolaus Kröger, Eduardo Olavarria
Publikováno v:
Haematologica, Vol 99, Iss 9 (2014)
Patients with chronic myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation may be treated by tyrosine kinase inhibitors and/or by donor lymphocyte infusions. The best strategies and timing of administration of lymphocyt
Externí odkaz:
https://doaj.org/article/55981cd4f0be48fa9ca573e4e027008f
Autor:
Judith C. W. Marsh, Régis Pefault de la Tour, Nicolaus Kröger, Kyle Hebert, Carlo Dufour, Carmel Rice, Ghulam J. Mufti, Jaap Jan Boelens, Nicolaas P. Schaap, Joseph Pidala, Victoria Potter, Neena Kapoor, Paolo Anderlini, Michael Hallek, Eefke Peterson, Andrew McDonald, Mary Eapen, Cora Knol, Herman Einsele, H. Joachim Deeg, Joseph H. Antin, Dirk Jan Eikema, Stijn Halkes, Johanna Tischer, Vikram Mathews, Hein Putter
Publikováno v:
Rice, C, Eikema, D J, Marsh, J C W, Knol, C, Hebert, K, Putter, H, Peterson, E, Deeg, H-J, Halkes, C J M, Pidala, J, Anderlini, P, Tischer, J, Kroger, N, McDonald, A, Antin, J H, Schaap, N P M, Hallek, M, Einsele, H, Mathews, V, Kapoor, N, Boelens, J J, Mufti, G J, Potter, V, Pefault de la Tour, R, Eapen, M & Dufour, C 2018, ' Allogeneic Hematopoietic Cell Transplantation in Patients aged 50 years or older with Severe Aplastic Anemia ', BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION . https://doi.org/10.1016/j.bbmt.2018.08.029
Biology of Blood and Marrow Transplantation, 25, 488-495
Biology of Blood and Marrow Transplantation, 25(3), 488. Elsevier Inc.
Biology of Blood and Marrow Transplantation, 25(3), 488-495
Biology of Blood and Marrow Transplantation, 25, 3, pp. 488-495
Biology of Blood and Marrow Transplantation, 25, 488-495
Biology of Blood and Marrow Transplantation, 25(3), 488. Elsevier Inc.
Biology of Blood and Marrow Transplantation, 25(3), 488-495
Biology of Blood and Marrow Transplantation, 25, 3, pp. 488-495
We report on 499 patients with severe aplastic anemia aged >= 50 years who underwent hematopoietic cell transplantation (HCT) from HLA-matched sibling (n = 275, 55%) or HLA-matched (8/8) unrelated donors (n =187, 37%) between 2005 and 2016. The media
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a116176d1ec0c5b67d9927f9ba8c4a52
https://dspace.library.uu.nl/handle/1874/391352
https://dspace.library.uu.nl/handle/1874/391352